Evidence Summaries

These evidence summaries are  intended to be used as an education resource and to assist with training and advice on the use of behaviour supports and the reduction and elimination of the use of restrictive practices by NDIS providers.

They have been prepared by the NDIS Quality and Safeguards Commission in the course of undertaking and publishing research to inform the development and evaluation of the use of behaviour supports and to develop strategies to encourage the reduction and elimination of restrictive practices by NDIS providers.

ADHD-related medications for behaviours of concern in children, adolescents and adults with autism

This evidence summary provides NDIS behaviour support practitioners and registered NDIS providers who implement behaviour support plans with the most up-to-date research evidence on the benefits and harms of ADHD-related medications when it is used to manage behaviours of concern in children, adolescents and adults with Autism Spectrum Disorder (ASD).

Anticonvulsants for behaviours of concern in children, adolescents and adults with autism

This evidence summary provides NDIS behaviour support practitioners and registered NDIS providers who implement behaviour plans with the most up-to-date research evidence on the benefits and harms of anticonvulsant medications when they are used to manage behaviours of concern in children, adolescents and adults with Autism Spectrum Disorder (ASD).

Antidepressants for behaviours of concern in children, adolescents and adolescents with autism

This evidence summary provides NDIS behaviour support practitioners and registered NDIS providers who implement behaviour support plans with the most up-to-date research evidence on the benefits and harms of antidepressants when they are used to manage behaviours of concern in children, adolescents and adults with Autism Spectrum Disorder (ASD).

Antipsychotics for behaviours of concern in children, adolescents and adults with autism

This evidence summary provides NDIS behaviour support practitioners and registered NDIS providers who implement behaviour support plans with the most up-to-date research evidence on the benefits and harms of antipsychotics when they are used to manage behaviours of concern in children, adolescents and adults with Autism Spectrum Disorder (ASD).

Neurohormones for behaviours of concern in children, adolescents and adults with autism

This evidence summary provides NDIS behaviour support practitioners and registered NDIS providers who implement behaviour support plans with the most up-to-date research evidence on the benefits and harms of neurohormones when they are used to manage behaviours of concern in children, adolescents and adults with Autism Spectrum Disorder (ASD).

Risperidone for behaviours of concern in children, adolescents and adults with autism

This evidence summary provides NDIS behaviour support practitioners and registered NDIS providers who implement behaviour support plans with the most up-to-date research evidence on the benefits and harms of risperidone when it is used to manage behaviours of concern in children, adolescents and adults with Autism Spectrum Disorder (ASD).